News Background

Oxford, UK – 09 February 2011. OGT, provider of innovative genetics and biomarker solutions to advance molecular medicine, has expanded its CytoSure® product range to include high-throughput genomic DNA labeling kits and sample tracking spike-ins. These new products will further streamline workflow and minimize sample tracking errors when performing array comparative genomic hybridization (aCGH). 

The new CytoSure HT Genomic DNA Labelling Kit makes it possible to simultaneously label up to 96 samples using a 96-well plate format, boosting cost-effectiveness, increasing processing speed and facilitating automated sample handling. The unique formulation and mastermix-based approach maximizes signal-to-noise ratio and reduces sample-to-sample variation, facilitating the confident detection of even the smallest aberrations. 

CytoSure ISCA Sample Tracking Spike-ins ensure that any potential sample mix-up during array processing can be easily identified, safeguarding against mistakes and maximizing data confidence. When used in combination with CytoSure ISCA arrays and OGT’s powerful CytoSure Interpret Software, these new products make it easy to correlate individual data sets with sample origin.  

Ruth Burton, OGT’s Product Manager Clinical Solutions, commented: “We regularly invite our customers to provide input into future product development in order to better meet their requirements. Developed in response to recent feedback, these new products provide efficient DNA labeling and dedicated sample tracking, maximizing precision in the aCGH workflow.”  

The new CytoSure HT Genomic DNA Labelling Kit and ISCA Sample Tracking Spike-ins expand the CytoSure range of products and services, to further broaden OGT’s cutting-edge cytogenetic solutions and provide market-leading accuracy, reliability and ease-of-use. 

You might also be interested in

Array Scientist Loads Sample

NHS study confirms higher reporting rate for OGT's CytoSure v3 array

22 Jul 2020

Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure® v3 vs traditional array design.

Read
NGS Scientist And Interpret Software

OGT launches breakthrough NGS panel for constitutional cytogenetics

30 Jan 2020

Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay.

Read
NGS Cytosure NGS Product Packaging

OGT develops transformative constitutional NGS panel

10 Dec 2019

CytoSure® NGS – Combining the benefits of microarrays and NGS in a single assay.

Read
All News
CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter